Medicine
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.
S. Grundy, J. Cleeman, Noel, B. Merz, H Bryan Brewer, L. Clark, D. Hunninghake, R. Pasternak, Sidney C. Smith, N. Stone
tlooto Summary
The trials confirm the benefit of cholesterol-lowering therapy in high-risk patients and support the ATP III treatment goal of low-density lipoprotein cholesterol (LDL-C) <100 mg/dL, and confirm that older persons benefit from therapeutic lowering of LDL-C.
Abstract
Abstract is not available.
Citation format
GRUNDY, S., et al. Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 44 3: 720–32.